Newsletter
Every new paper in this field, in your inbox.
Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).
A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.
Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.
Roux-en-Y gastric bypass (RYGB) reversal is rare but offers significant symptom relief for select patients with complications.
Surgeons should be alert to significant issues in the implementation of non-standard metabolic bariatric surgeries.
A novel magnetic compression gastroileostomy bipartition (MagGI) shows promising early outcomes in patients needing revisional surgery after sleeve gastrectomy.
Patients with obesity undergoing non-bariatric surgery who follow low-energy diets show promise for better outcomes.
Surgeons should recognize that managing obesity could notably decrease cancer rates among patients.
Gas bloat syndrome significantly worsens outcomes after Nissen fundoplication, revealing critical insights for surgical practice.
One-anastomosis gastric bypass leads to greater weight loss but carries higher gastrointestinal complication risks compared to sleeve gastrectomy.
